Agile Therapeutics
Stock Forecast, Prediction & Price Target
Agile Therapeutics Financial Estimates
Agile Therapeutics Revenue Estimates
Agile Therapeutics EBITDA Estimates
Agile Therapeutics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $4.10M N/A | $10.88M 165.39% | $19.59M 80.01% | Avg: $50.93M Low: $50.93M High: $50.93M avg. 159.94% | Avg: $66.28M Low: $66.28M High: $66.28M avg. 30.15% | Avg: $96.33M Low: $96.33M High: $96.33M avg. 45.32% | |
Net Income
% change YoY
| $-76.58M N/A | $-25.41M 66.81% | $-14.46M 43.07% | Avg: $13.26M Low: $2.37M High: $2.37M avg. 191.66% | Avg: $23.90M Low: $4.24M High: $4.24M avg. 80.27% | Avg: $7.48M Low: $7.48M High: $7.48M avg. -68.69% | |
EBITDA
% change YoY
| $-70.98M N/A | $-41.35M 41.73% | $-19.88M 51.91% | Avg: $-30.46M Low: $-30.46M High: $-30.46M avg. -53.23% | Avg: $-39.65M Low: $-39.65M High: $-39.65M avg. -30.15% | Avg: $-57.63M Low: $-57.63M High: $-57.63M avg. -45.32% | |
EPS
% change YoY
| -$63,115.49 N/A | -$58.79 99.90% | -$6.71 88.58% | Avg: $1.1 Low: $1.1 High: $1.1 avg. 116.39% | Avg: $1.97 Low: $1.97 High: $1.97 avg. 79.09% | Avg: $3.47 Low: $3.47 High: $3.47 avg. 76.14% | |
Operating Expenses
% change YoY
| $64.38M N/A | $45.48M -29.36% | $30.49M -32.94% | Avg: $698.68M Low: $698.68M High: $698.68M avg. 2190.84% | Avg: $909.35M Low: $909.35M High: $909.35M avg. 30.15% | Avg: $1.32B Low: $1.32B High: $1.32B avg. 45.32% | |
FAQ
What is Agile Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 67.74% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is 2.37M, average is 13.26M and high is 2.37M.
What is Agile Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 78.47% in 2025-2027.
We have gathered data from 1 analysts. Their low revenue estimate is $50.93M, average is $50.93M and high is $50.93M.
What is Agile Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 90.54% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is $1.1, average is $1.1 and high is $1.1.
What is the best performing analyst?
In the last twelve months analysts have been covering Agile Therapeutics stock. The most successful analyst is Caroline Palomeque whose win rate is 100%. He has correctly predicted 1/1 price targets.